PubMed COVID-19 Clinical Care
36851 - 36860 of 44979 results found
PM2.5 carbonaceous components and mineral dust at a COALESCE network site - Bhopal, India: Assessing the impacts of COVID-19 lockdowns on site-specific optical properties
Description
Thermal elemental carbon (EC), optical black carbon (BC), organic carbon (OC), mineral dust (MD), and 7-wavelength optical attenuation of 24-hour ambient PM(2.5) samples were characterized/estimated at a regionally representative site (Bhopal
Current Therapeutic Delivery Approaches Using Nanocarriers for the Treatment of Tuberculosis Disease
Description
Tuberculosis is a major health issue globally and a leading cause of death due to the infective microorganism Mycobacterium tuberculosis. Treatment of drug resistance tuberculosis requires longer treatment with multiple daily doses of drugs
Industry Payments to Radiologists During the last five years and impact of COVID-19 Pandemic
Description
CONCLUSIONS: There was significant decline in overall industry payments coinciding with the COVID pandemic, with biggest declines in gifts and speaker fees. The impact on the different categories of payments and recovery in the last two years has
Infectious diseases in Indigenous populations in North America: learning from the past to create a more equitable future
Description
The COVID-19 pandemic, although a profound reminder of endured injustices by and the disparate impact of infectious diseases on Indigenous populations, has also served as an example of Indigenous strength and the ability to thrive anew. Many
RNA extraction-free workflow integrated with a single-tube CRISPR-Cas-based colorimetric assay for rapid SARS-CoV-2 detection in different environmental matrices
Description
On-site environmental surveillance of viruses is increasingly important for infection prevention and pandemic control. Herein, we report a facile single-tube colorimetric assay for detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2
Secondary infections in critically ill patients with COVID-19: A retrospective single-center study
Description
CONCLUSION: The incidence of secondary bacterial infections was high in critically ill patients with COVID-19 and was associated with a longer duration of admission to the hospital and ICU and a higher mortality. Diabetes mellitus and cumulative dose
Comments on the systemic corticosteroid strategy for the coronavirus disease 2019 (COVID-19)
Description
Systemic corticosteroid is considered effective in treating severe or critical coronavirus disease 2019 (COVID-19) patients in both Chinese and international consensus and/or guidelines. Dexamethasone (6 mg daily for up to 10 days) is usually
Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters
Description
BACKGROUND: Convalescent plasma (CP) transfusion is an early option for treating infections with pandemic potential, often preceding vaccine or antiviral drug rollout. Heterogenous findings from randomized clinical trials on transfusion of COVID-19
